133 related articles for article (PubMed ID: 34896434)
1. Apple polyphenol phloretin complexed with ruthenium is capable of reprogramming the breast cancer microenvironment through modulation of PI3K/Akt/mTOR/VEGF pathways.
Roy S; Mondru AK; Chakraborty T; Das A; Dasgupta S
Toxicol Appl Pharmacol; 2022 Jan; 434():115822. PubMed ID: 34896434
[TBL] [Abstract][Full Text] [Related]
2. A coordinated ruthenium-rifampicin complex reprogramming the colon carcinoma micro-environment mediated by modulation of p53/AkT/mTOR/VEGF pathway.
Zeng J; Zhao Y; Li K; Long D; Li W; Liang L
Toxicol Appl Pharmacol; 2021 Sep; 426():115618. PubMed ID: 34126112
[TBL] [Abstract][Full Text] [Related]
3. A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway.
Liang W; Shi J; Xia H; Wei X
Oxid Med Cell Longev; 2021; 2021():5537737. PubMed ID: 34221232
[TBL] [Abstract][Full Text] [Related]
4. Potentiating apoptosis and modulation of p53, Bcl2, and Bax by a novel chrysin ruthenium complex for effective chemotherapeutic efficacy against breast cancer.
Roy S; Sil A; Chakraborty T
J Cell Physiol; 2019 Apr; 234(4):4888-4909. PubMed ID: 30246261
[TBL] [Abstract][Full Text] [Related]
5. Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events.
Jin G; Zhao Z; Chakraborty T; Mandal A; Roy A; Roy S; Guo Z
Oxid Med Cell Longev; 2020; 2020():7690845. PubMed ID: 32566099
[TBL] [Abstract][Full Text] [Related]
6. Construing the Biochemical and Molecular Mechanism Underlying the
Wang Y; Bian L; Chakraborty T; Ghosh T; Chanda P; Roy S
Int J Biol Sci; 2019; 15(5):1052-1071. PubMed ID: 31182925
[TBL] [Abstract][Full Text] [Related]
7. Caspase-dependent and caspase-independent induction of apoptosis in breast cancer by fucoidan via the PI3K/AKT/GSK3β pathway in vivo and in vitro.
Xue M; Ji X; Xue C; Liang H; Ge Y; He X; Zhang L; Bian K; Zhang L
Biomed Pharmacother; 2017 Oct; 94():898-908. PubMed ID: 28810530
[TBL] [Abstract][Full Text] [Related]
8. Vanadium quercetin complex attenuates mammary cancer by regulating the P53, Akt/mTOR pathway and downregulates cellular proliferation correlated with increased apoptotic events.
Roy S; Banerjee S; Chakraborty T
Biometals; 2018 Aug; 31(4):647-671. PubMed ID: 29855745
[TBL] [Abstract][Full Text] [Related]
9. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells.
Kamal A; Lakshma Nayak V; Nagesh N; Vishnuvardhan MV; Subba Reddy NV
Bioorg Chem; 2016 Jun; 66():124-31. PubMed ID: 27149364
[TBL] [Abstract][Full Text] [Related]
10. The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter.
Wu KH; Ho CT; Chen ZF; Chen LC; Whang-Peng J; Lin TN; Ho YS
J Food Drug Anal; 2018 Jan; 26(1):221-231. PubMed ID: 29389559
[TBL] [Abstract][Full Text] [Related]
11. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
[TBL] [Abstract][Full Text] [Related]
12. Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness.
De P; Sun Y; Carlson JH; Friedman LS; Leyland-Jones BR; Dey N
Neoplasia; 2014 Jan; 16(1):43-72. PubMed ID: 24563619
[TBL] [Abstract][Full Text] [Related]
13. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
14. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
Huang KF; Zhang GD; Huang YQ; Diao Y
Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
[TBL] [Abstract][Full Text] [Related]
15. Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer.
Ibrahim SSA; El-Aal SAA; Reda AM; Achy SE; Shahine Y
Sci Rep; 2022 Jul; 12(1):11514. PubMed ID: 35798765
[TBL] [Abstract][Full Text] [Related]
16. The apple dihydrochalcone phloretin suppresses growth and improves chemosensitivity of breast cancer cells via inhibition of cytoprotective autophagy.
Chen M; Gowd V; Wang M; Chen F; Cheng KW
Food Funct; 2021 Jan; 12(1):177-190. PubMed ID: 33291138
[TBL] [Abstract][Full Text] [Related]
17. Phloretin induces cell cycle arrest and apoptosis of human glioblastoma cells through the generation of reactive oxygen species.
Liu Y; Fan C; Pu L; Wei C; Jin H; Teng Y; Zhao M; Yu AC; Jiang F; Shu J; Li F; Peng Q; Kong J; Pan B; Zheng L; Huang Y
J Neurooncol; 2016 Jun; 128(2):217-23. PubMed ID: 26983952
[TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231).
Balakrishnan S; Mukherjee S; Das S; Bhat FA; Raja Singh P; Patra CR; Arunakaran J
Cell Biochem Funct; 2017 Jun; 35(4):217-231. PubMed ID: 28498520
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231.
Xu T; Liu P; Li Q; Shi C; Wang X
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):828-834. PubMed ID: 33218396
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium polypyridyl complex inhibits growth and metastasis of breast cancer cells by suppressing FAK signaling with enhancement of TRAIL-induced apoptosis.
Cao W; Zheng W; Chen T
Sci Rep; 2015 Mar; 5():9157. PubMed ID: 25778692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
